Genentech, Inc. - Strategic SWOT Analysis Review

Date: February 4, 2016
Pages: 44
Price:
US$ 125.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: G0ADAA36950EN
Leaflet:

Download PDF Leaflet

Genentech, Inc. - Strategic SWOT Analysis Review
Genentech, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – GlobalData’s summarization of the company’s business strategy.
  • SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
Highlights

Genentech, Inc. (Genentech) is a biotech company that undertakes discovery, development, manufacture and commercialization of medicines for the treatment of patients with serious medical conditions. The company focuses on developing drugs for unmet medical needs in the areas of oncology, immunology, neuroscience, metabolism, infectious disease, ophthalmology and bioinformatics. Some of its products include Rituxan, Avastin, Herceptin, Tarceva, Lucentis, Xolair, Pulmozyme, Activase and others. Genentech research activities focus on areas of cancer, metabolism, immunology, infectious disease and neuroscience.

Genentech, Inc. Key Recent Developments

Oct 08,2015 Accelerated Cure Project receives additional funding for the multicenter longitudinal OPT-UP clinical study in MS
Sep 21,2015 Xenon Pharmaceuticals Achieves Milestone in Genentech Collaboration to Discover Novel Pain Targets
Sep 07,2015 Genentech to Present Data from 15 Medicines Across Its Portfolio of Cancer Immunotherapy and Targeted Medicines During the 2015 European Cancer Congress
Jul 13,2015 AC Immune receives milestone in Anti-Tau Antibody collaboration with Genentech
Jun 15,2015 Almac Discovery Announce Ubiquitin Specific Protease Collaboration with GenentechReasons to Buy
  • Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
  • Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
  • Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
  • Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Note: Some sections may be missing if data is unavailable for the company.
SECTION 1 - ABOUT THE COMPANY

Genentech, Inc. - Key Facts
Genentech, Inc. - Key Employees
Genentech, Inc. - Major Products and Services
Genentech, Inc. - Pharmaceutical Pipeline Products Data
Genentech, Inc., Pipeline Products by Therapy Area
Genentech, Inc., Pipeline Products by Development Phase
Genentech, Inc. - History
Genentech, Inc. - Company Statement
Genentech, Inc. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Genentech, Inc. - Key Manufacturing Facilities

SECTION 2 – COMPANY ANALYSIS

Genentech, Inc. - Business Description
Genentech, Inc. - Corporate Strategy
Genentech, Inc. - SWOT Analysis
SWOT Analysis - Overview
Genentech, Inc. - Strengths
Strength - Product Base
Strength - Manufacturing Capabilities
Strength - Synergy through Roche
Genentech, Inc. - Weaknesses
Weakness - Legal Proceedings
Genentech, Inc. - Opportunities
Opportunity - Growing Incidence of Cancer Provides Opportunity for Growth
Opportunity - Product Approvals
Opportunity - Rising Healthcare Expenditure in the US
Genentech, Inc. - Threats
Threat - Competitive Landscape
Threat - Stringent Government Regulations
Threat - Uncertain R&D Outcomes
Genentech, Inc. - Key Competitors

SECTION 3 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Genentech, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Genentech, Inc., Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
Genentech, Inc., Recent Deals Summary

SECTION 4 – COMPANY’S RECENT DEVELOPMENTS

Oct 08, 2015: Accelerated Cure Project receives additional funding for the multicenter longitudinal OPT-UP clinical study in MS
Sep 21, 2015: Xenon Pharmaceuticals Achieves Milestone in Genentech Collaboration to Discover Novel Pain Targets
Sep 07, 2015: Genentech to Present Data from 15 Medicines Across Its Portfolio of Cancer Immunotherapy and Targeted Medicines During the 2015 European Cancer Congress
Jul 13, 2015: AC Immune receives milestone in Anti-Tau Antibody collaboration with Genentech
Jun 15, 2015: Almac Discovery Announce Ubiquitin Specific Protease Collaboration with Genentech
Jan 14, 2015: Human Longevity Signs Agreement with Genentech for Whole Genome Sequencing and Analysis of Samples

SECTION 5 – APPENDIX

Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Genentech, Inc., Key Facts
Genentech, Inc., Key Employees
Genentech, Inc., Major Products and Services
Genentech, Inc., Number of Pipeline Products by Therapy Area
Genentech, Inc., Number of Pipeline Products by Development Stage
Genentech, Inc., Pipeline Products By Therapy Area and Development Phase
Genentech, Inc., History
Genentech, Inc., Other Locations
Genentech, Inc., Key Manufacturing Facilities
Genentech, Inc., Key Competitors
Genentech, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Genentech, Inc., Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
Genentech, Inc., Recent Deals Summary

LIST OF FIGURES

Genentech, Inc., Pipeline Products by Therapy Area
Genentech, Inc., Pipeline Products by Development Phase
Genentech, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Genentech, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016
Skip to top


Ask Your Question

Genentech, Inc. - Strategic SWOT Analysis Review
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: